Alarming Rise in Cancer Cases Driving Market for Ablation Technologies

Ablation refers to the removal of material from the surface of any object via various erosive processes. In the field of medicine, ablation technologies are used to surgically remove parts of unwanted biological tissue from the body. Various energy devices such as microwave, radiofrequency, electrical current, ultrasound, and laser are employed in various medical disciplines including gynecology, cardiovascular, pain management, oncology, ophthalmology, and urology. While ablation technologies are most commonly used in surgical procedures for the treatment of cardiovascular disorders such as arrhythmias, atrial fibrillation, and refractory hypertension, they are also increasingly used in the removal of cancerous as well as non-cancerous tumors.

A report published by Transparency Market Research studies the workings of the global ablation technologies market and states that the market is projected to record a healthy CAGR of 12.10% from 2014 to 2020, the report’s forecast period. During this time, the value of the worldwide market for ablation technologies is anticipated to rise from US$4.6 bn in 2013 to US$10.6 bn in 2020.

Factors Responsible for Growth of Ablation Technologies

The ablation technologies market, as mentioned above, is poised to witness rapid growth over the next five years. This growth can be attributed to factors including:

•    Rapidly aging population
•    Technological advancements in the field of ablation devices
•    Growing demand for minimally invasive surgeries
•    Rising prevalence of cardiovascular diseases and cancer
•    Growth of medical tourism in emerging markets such as India, China, Mexico, and Brazil
•    Government initiatives aimed at modernization of healthcare systems
•    Favorable regulatory environment
•    Increasing adoption of ablation techniques in cosmetology
•    Growing acceptance of novel technologies in developed countries
•    Availability of extensive line of radiofrequency ablation and cryoablation tools for the diagnosis and treatment of various cardiac arrhythmias.

Major Developments in the Field of Ablation Technology

The demand for minimally invasive surgical procedures has pushed manufacturers and scientists to develop newer devices and technologies that will result in better patient outcomes and faster recovery.

Just last month, the US Food and Drug Administration (FDA) approved a treatment option for excessive menstrual bleeding. The endometrial ablation system has been developed by Minerva Surgical, Inc. and is designed for the ablation of the uterus’ endometrial lining in pre-menopausal women who suffer from excessive menstrual bleeding. This bleeding is most often caused by benign reasons. The latest system uses heat to adequately ablate the endometrium via three separate ablation mechanisms. The procedure takes around three to four minutes. This has proven to be a safer and more effective way of treating excessive menstrual bleeding or menorrhagia. 

Other companies that have earned a place for themselves on the list of leading players in the ablation technologies market include St. Jude Medical, Inc., AngioDynamics, Inc., Covidien plc, BSD Medical Corporation, AtriCure, Inc., Medtronic, Inc., Urologix, Inc., Boston Scientific Corporation, and Biosense Webster Inc.


Post a Comment

Note: only a member of this blog may post a comment.

Latest Post

Market Research Reports